Results

Total Results: 1,187 records

Showing results for "week".

241. Comparative Effectiveness of Second Generation Antidepressants in the Pharmacologic Treatment of Adult Depression—An Update to a 2007 Report. (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_disposition-comments.pdf
     December 01, 2011 - effectiveness research review is posted to the EHC Program Web site in draft form for public comment for a 4-week

242. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-270-bimp-disposition-comments.pdf
     September 18, 2024 - draft report is posted to the EHC Program website or AHRQ website for public comment for a 3- to 4-week

243. Methods Research Report: Developing Consistent and Useful Quality Improvement Study Data Extraction (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/developing-consistent-useful-quality-improvement.pdf
     September 01, 2020 - length of intervention: 12 months Duration of intervention: 4 sessions of 1 to 1.25h, one every week … Length of intervention: 1 year Children and family: 2 sessions of two hours each, one week apart … One session + supplementary session for chief investigator; 3-4 visits for GP Once a week for 4 … weeks Children and family: two sessions one week apart. … intervention; PLE = peer leader education; RCT = randomized controlled trial; US = United States; WK = week

244. Crohns-Disease Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_executive.pdf
     February 01, 2014 - Crohn’s is not a 6-week disease: lifelong management of mild to moderate Crohn’s disease.

245. Management of Suicidal Thoughts and Behaviors in Youth: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-exe-sum.pdf
     April 01, 2025 - where 50 percent achieved remission of depression (Children’s Depression Rating Scale [CDRS]< 28) by week … 24 but 15.1 percent of the sample had a suicide attempt by week 24.

246. Disposition of Comments for CER 202 Effectiveness and Safety of Bronchial Thermoplasty in the Management of Asthma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-202-thermoplasty-comments.pdf
     December 14, 2017 - is posted to the EHC Program Web site or AHRQ Web site in draft form for public comment for a 3-4-week … reduction in severe exacerbations (Low SOE) and emergency room visits (Moderate SOE) after the 12-week … measures, clarifying that the only report of improvement in FEV1 was in the RISA trial at the 22-week … and standard care (Moderate SOE).18Serious adverse events attributed to BT occurred during the 12-week … Published Online: December 14, 2017 47 Commentator & Affiliation Section Comment Response the 12-week

247. Radiotherapy-Proton-Beam Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiotherapy-proton-beam_research.pdf
     May 01, 2012 - of claims suggests that ocular tumors typically receive a relatively short course of therapy (one week … expansion will be fur- ther multiplied by the fact that with 6 to 8 weeks of therapy (compared to one week

248. TND-0543_05-24-2013 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0543_05-24-2013.pdf
     January 01, 2013 - TND-0543_05-24-2013 Acute Cough Illness Nomination Summary Document Results of Topic Selection Process & Next Steps  Acute Cough Illness (ACI) will go for…

249. Behavioral Programs To Help Manage Type 2 Diabetes: A Review of the Research for Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_consumer.pdf
     November 01, 2016 - You will likely meet with the provider one or more times a week for at least a month.

250. Behavioral Programs To Help Manage Type 1 Diabetes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_consumer-2016.pdf
     January 01, 2016 - You will likely meet with the provider one or more times a week for at least a month.

251. Executive summary_Comparative Effectiveness Review No. 270: Behavioral Interventions for Migraine Prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-270-bimp-executive-summary.pdf
     May 01, 2024 - suggesting potential benefits of behavioral sleep modification in reducing headache frequency at 6-week

252. Major-Depressive-Disorder Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/major-depressive-disorder_executive.pdf
     December 01, 2015 - 1 Comparative Effectiveness Review Number 161 Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder Executive Summary Background Major depressive disorder (MDD)1 is the most prevalent and disabling form of depression, affecting more than 16 percent of U.S…

253. Depression-Postpartum-Screening Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_executive.pdf
     May 01, 2013 - standard diagnostic criteria—namely, five or more of the following symptoms present during the same 2-week

254. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
     January 01, 2015 - 650 added to therapy reportedly enabled 25% of patients to reach an HbA1c goal of less than 7% at week … ITCA 650 was added to their regimens, 25% of these patients reached an HbA1c goal of less than 7% by week

255. Executive Summary_Comparative Effectiveness Review No. 259: Partial Breast Irradiation for Breast Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-259-partial-breast-irradiation-executive-summary.pdf
     January 01, 2023 - Executive Summary_Comparative Effectiveness Review No. 259: Partial Breast Irradiation for Breast Cancer Comparative Effectiveness Review Number 259 Partial Breast Irradiation for Breast Cancer Executive Summary Main Points • There was no significant difference between partial breast irrad…

256. Pharmacotherapy for Adults with Alcohol-Use Disorders in Outpatient Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy-surveillance.pdf
     September 01, 2017 - 1220 ) showed that acamprosate was beneficial for non- obese participants with shorter abstinence (1 week … naltrexone was not superior to placebo to reduce drinking (heavy drinking days or average drinks per week … Doxazosin (The parent study was not included; only 10 week duration). … Heavy drinkers (n=41) with a standing dBP >=80 mmHg showed reduced drinks per week and heavy drinking … Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: a 12-week

257. Psychological and Pharmacological Treatments for Adults with Posttraumatic (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-adult-treatment-update_research-protocol.pdf
     December 31, 2017 - • Can be used to make a current or lifetime diagnosis of PTSD or to assess symptoms over the past week … • Past week, past month, and worst month (lifetime) PTSD can be estimated. … “intrusions,” “avoidance,” and emotional numbing related to stressful events occurred in the last week

258. Partial Breast Irradiation for Breast Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/partial-breast-irradiation-disposition-comments.pdf
     January 31, 2023 - draft report is posted to the EHC Program website or AHRQ website for public comment for a 3- to 4-week … I presume for WBI the short-term AEs were at week 6 for most patients.

259. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
     September 26, 2014 - At week 52, IDeg Free-Flex subjects had similar glycosylated hemoglobin but greater fasting plasma … hypoglycemia was lower with IDeg Forced-Flex vs IDeg (37%; P = .003) and IGlar (40%; P = .001) at week … 26 and 25% lower with IDeg Free-Flex vs IGlar (P = .026) at week 52. … glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase … randomized, treat-to-target trial with a 26-week extension.

260. SRDR-Charter-140305 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/data-repository-reviews-charter-140305.pdf
     June 01, 2012 - . − The SRDR operational team will send  meeting  materials no  later than one week before the